IMAX stock performance snapshot
IMAX (IMAX) is back on radar for some investors after recent share price moves, with the stock up about 1.7% over the past day but showing an 8.0% decline over the past month.
That short term pullback sits alongside a 4.5% gain over the past 3 months and a 7.3% return year to date. This underlines how volatile shorter windows can look when you zoom in.
See our latest analysis for IMAX.
At a share price of $38.64, IMAX has paired a recent 8.0% one month share price pullback with a much stronger backdrop, including a 45.37% one year total shareholder return that suggests sentiment has improved over time even as shorter term momentum has cooled.
If you are curious about where else strong narratives and price moves might be forming around media and technology themes, this is a good moment to scan 20 top founder-led companies
With IMAX trading at $38.64 against a $45.00 analyst target and an estimated intrinsic value gap, plus solid recent revenue and net income growth, is the market offering you a mispriced media platform or already baking in future gains?
Most Popular Narrative: 14.1% Undervalued
IMAX's most followed valuation story pegs fair value at $45.00 compared with the last close at $38.64, and that gap is built on specific growth and margin assumptions rather than sentiment alone.
Operating leverage from cost discipline, capital light joint venture models, and advances in proprietary projection or distribution technology, for example streaming for live events, is associated with sustained margin expansion and cash generation, directly affecting net margins and enabling opportunistic reinvestment or shareholder returns.
Want to see what type of revenue trajectory and profit profile could support that valuation gap? The narrative refers to rising earnings power, richer margins, and a future earnings multiple more often associated with larger media platforms, all tied to specific long term box office and content assumptions.
Result: Fair Value of $45.00 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this hinges on cinema attendance and blockbuster output holding up, while rising competition from other premium formats could put pressure on IMAX's margins and pricing power.
Find out about the key risks to this IMAX narrative.
Another angle on IMAX's valuation
The narrative prices IMAX at a fair value of $45.00 using growth and margin forecasts, yet the current P/E of 59.8x is above both the US Entertainment industry average of 35.7x and an estimated fair ratio of 26x. That premium can signal confidence, but also raises the question of how much upside is already priced in.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With sentiment clearly mixed, this is a good time to look at the numbers yourself, weigh the trade off, and see how IMAX's 3 key rewards and 2 important warning signs
Looking for more investment ideas?
If IMAX has sharpened your focus, do not stop here. Broaden your watchlist now so you are not late to the next opportunity.
- Spot potential value plays early by scanning 63 high quality undervalued stocks before others catch on.
- Prioritise resilience by using the 65 resilient stocks with low risk scores to see companies with lower risk scores that may better fit your comfort zone.
- Hunt for lesser known standouts through the screener containing 25 high quality undiscovered gems and give yourself a chance to find ideas off the usual radar.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com